Rankings
▼
Calendar
GRAL (GRAIL, Inc.) Stock Financials & Earnings | Market Cap Arena
GRAL
GRAIL, Inc.
Mkt Cap
$2B
Healthcare
·
Medical - Diagnostics & Research
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$147M
Net Income (TTM)
-$408M
EPS (TTM)
-$11.18
Free Cash Flow (TTM)
-$299M
Gross Margin
-42.5%
Op. Margin
-363.0%
Net Margin
-277.5%
FCF Margin
-203.2%
P/S Ratio (TTM)
13.2x
P/E Ratio (TTM)
—
YoY Rev Growth
+17.2%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$20M
-$26M
-$204M
Q2 23
$22M
-$24M
-$204M
Q3 23
$21M
-$27M
-$912M
Q4 23
$30M
-$19M
-$195M
Q1 24
$27M
-$22M
-$227M
Q2 24
$32M
-$18M
-$1.6B
Q3 24
$29M
-$22M
-$184M
Q4 24
$38M
-$16M
-$137M
Q1 25
$32M
-$20M
-$154M
Q2 25
$36M
-$18M
-$159M
Q3 25
$36M
-$14M
-$125M
Q4 25
$44M
-$11M
-$96M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
20.8x
—
Q1 24
19.3x
—
Q2 24
17.6x
—
Q3 24
16.5x
—
Q4 24
15.4x
—
Q1 25
14.8x
—
Q2 25
14.4x
—
Q3 25
13.7x
—
Q4 25
13.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$170M
-$174M
Q2 23
-$139M
-$142M
Q3 23
-$158M
-$161M
Q4 23
-$129M
-$133M
Q1 24
-$207M
-$210M
Q2 24
-$172M
-$173M
Q3 24
-$105M
-$106M
Q4 24
-$93M
-$94M
Q1 25
-$95M
-$95M
Q2 25
-$77M
-$77M
Q3 25
-$63M
-$64M
Q4 25
-$64M
-$63M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$3M
Q2 23
$3M
Q3 23
$3M
Q4 23
$4M
Q1 24
$3M
Q2 24
$1M
Q3 24
$971K
Q4 24
$303K
Q1 25
$62K
Q2 25
$369K
Q3 25
$384K
Q4 25
$815K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 24
+36.0%
+13.6%
Q2 24
+42.6%
+637.8%
Q3 24
+38.3%
-77.3%
Q4 24
+26.1%
-22.1%
Q1 25
+19.1%
-27.0%
Q2 25
+11.2%
-88.4%
Q3 25
+26.3%
-23.9%
Q4 25
+14.0%
-20.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$22M
109.5%
Q2 23
$26M
114.0%
Q3 23
$25M
122.2%
Q4 23
$25M
81.9%
Q1 24
$29M
108.9%
Q2 24
$26M
81.2%
Q3 24
$17M
60.9%
Q4 24
$14M
35.5%
Q1 25
$16M
50.9%
Q2 25
$14M
39.9%
Q3 25
$14M
39.1%
Q4 25
-$45M
-102.1%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$86M
$47M
$46M
—
Q2 23
$89M
$51M
$41M
—
Q3 23
$80M
$50M
$37M
—
Q4 23
$84M
$53M
$39M
—
Q1 24
$102M
$57M
$47M
—
Q2 24
$94M
$67M
$41M
—
Q3 24
$78M
$47M
$36M
—
Q4 24
$48M
$42M
$31M
—
Q1 25
$54M
$45M
$35M
—
Q2 25
$47M
$38M
$29M
—
Q3 25
$49M
—
—
$63M
Q4 25
$47M
$39M
$28M
—
marketcaparena.com
Revenue by Geography
Americas
Non-US
United States
Quarter
Americas
Non-US
United States
Q1 25
$29M
$2M
—
Q2 25
—
$1M
$34M
Q3 25
—
$3M
$33M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 23
$97M
$0
$97M
Q1 24
$974M
$0
$974M
Q2 24
$959M
$0
$959M
Q3 24
$854M
$0
$854M
Q4 24
$214M
$549M
$763M
Q1 25
$134M
$541M
$675M
Q2 25
$127M
$475M
$603M
Q3 25
$127M
$413M
$540M
Q4 25
$250M
$655M
$904M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
31M
—
Q2 23
31M
-0.0%
Q3 23
31M
+0.0%
Q4 23
31M
+0.0%
Q1 24
31M
+0.0%
Q2 24
31M
-0.0%
Q3 24
32M
+2.7%
Q4 24
32M
+0.1%
Q1 25
34M
+7.5%
Q2 25
35M
+2.2%
Q3 25
36M
+3.1%
Q4 25
41M
+12.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
—
—
FY 24
$718
175K
FY 25
$841
175K
marketcaparena.com